Endo International plc (ENDPQ) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Conference Call March 13, 2025 8:00 AM ETCompany ParticipantsLaure Park - Senior Vice President ...
Multiple Sclerosis News Today23h
FDA approves prefilled syringe formulation of Ani’s Cortrophin Gel
The FDA approved a prefilled syringe format for Ani's purified Cortrophin Gel that should ease administration for MS patients ...
Pharmaceutical Technology23h
Mallinckrodt and Endo sign $6.7bn merger deal
The two companies are merging after previously filing for bankruptcy due to opioid-related litigation and financial losses.
Wachtell, Davis Polk Steer Mallinckrodt's $6.7 Billion Merger With Endo
Wachtell, Lipton, Rosen & Katz is steering Mallinckrodt Pharmaceuticals and Davis Polk & Wardwell is guiding Endo Inc. in ...
Mallinckrodt Pharma, Endo Reach Deal for $6.7 Billion Merger
Mallinckrodt Pharmaceuticals and Endo Inc. plan to merge and create a $6.7 billion company in a move that will cut costs and broaden access to patients and new treatments.
Drugmakers Mallinckrodt, Endo agree to merge in nearly $7 billion deal
Endo shareholders will get $80 million in cash and own 49.9 per cent of the combined company, while Mallinckrodt shareholders ...
Drugmakers Mallinckrodt and Endo get a bump from tariffs in $6.7 billion merger
Endo shareholders will get $80 million in cash and own 49.9% of the combined company, while Mallinckrodt shareholders will ...
Healio28d
Non-Pharmacologic Therapies
In addition to pharmacologic therapies, patients with dermatomyositis (DM) should make some modifications to their lifestyle to optimize their care. In addition to pharmacologic therapies ...
Healio28d
Topical Pharmacological Management for Skin
Suggested first-line treatments for cutaneous symptoms include photoprotection, topical emollients, moisturizers, and topical anti-inflammatory medications. Photoprotection with sunscreen ...